We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| AARTI DRUGS LTD. | 6,528.80 | 451.60 | 6,527.90 | 4.95 | 4,320 | 22.9 |
| INDRAPRASTHA MEDICAL CORP.LTD. | 3884.0 | 494.6 | 3810.3 | 5.4 | 4096 | 24.4 |
| RPG LIFE SCIENCES LTD. | 1862.2 | 368.5 | 1816.8 | 0 | 3813 | 36.8 |
Aarti Drugs Limited, with Security Code 524348, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 538.2 | 559.5 | 493.0 | 543.1 | 514.5 | 623.0 | 521.0 | 579.0 |
| Expenses | 478.5 | 490.5 | 438.7 | 483.6 | 454.3 | 534.3 | 457.0 | 503.8 |
| Operating Profit | 59.7 | 69.1 | 54.2 | 59.5 | 60.3 | 88.7 | 64.0 | 75.2 |
| OPM % | 11.1% | 12.34% | 11% | 10.96% | 11.71% | 14.23% | 12.28% | 12.99% |
| Other Income | 1.7 | 1.1 | 0.1 | 0.4 | 11.4 | 1.7 | 0.4 | 0.2 |
| Interest | 6.8 | 8.1 | 7.5 | 7.2 | 7.6 | 7.5 | 6.8 | 6.0 |
| Depreciation | 11.8 | 12.3 | 11.7 | 11.9 | 12.0 | 12.2 | 12.3 | 13.6 |
| Profit before tax | 42.9 | 49.7 | 35.2 | 40.9 | 52.0 | 70.7 | 45.3 | 55.8 |
| Tax % | -26.2% | -27.3% | -23.5% | 25.7% | 25.9% | -12.9% | -7.5% | 25.1% |
| Net Profit | 31.6 | 36.1 | 26.9 | 30.4 | 38.5 | 61.5 | 48.6 | 41.8 |
| EPS in Rs | 3.44 | 3.93 | 2.93 | 3.33 | 4.22 | 0 | 5.33 | 4.58 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 641.5 | 605.9 | 620.0 | 555.3 | 598.3 | 556.6 | 676.8 | 652.8 |
| Expenses | 565.1 | 535.8 | 534.2 | 490.4 | 531.3 | 494.9 | 583.4 | 568.5 |
| Operating Profit | 76.5 | 70.1 | 85.8 | 65.0 | 67.1 | 61.7 | 93.4 | 84.3 |
| OPM % | 11.92% | 11.58% | 13.84% | 11.7% | 11.21% | 11.09% | 13.8% | 12.91% |
| Other Income | 0.7 | 1.7 | 1.1 | 1.1 | 1.5 | 11.9 | 1.9 | 0.1 |
| Interest | 8.3 | 7.6 | 9.1 | 8.7 | 8.9 | 9.1 | 9.2 | 7.7 |
| Depreciation | 12.6 | 12.7 | 13.6 | 13.4 | 13.7 | 13.8 | 14.9 | 16.3 |
| Profit before tax | 56.3 | 51.6 | 64.2 | 44.0 | 45.9 | 50.8 | 71.2 | 60.4 |
| Tax % | -29.6% | -28.8% | -26.3% | 24.4% | -23.8% | -26.9% | -11.7% | -25.2% |
| Net Profit | 39.6 | 36.7 | 47.3 | 33.3 | 35.0 | 37.1 | 62.8 | 45.2 |
| EPS in Rs | 4.29 | 3.99 | 5.15 | 3.62 | 3.83 | 4.06 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 4% |
| 1 Year: | -3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 4% |
| 3 Years: | -6% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 4% |
| 1 Year: | -3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|